Changes in the dependence of Pseudomonas aeruginosa o serogroup strains and their resistance to antibiotics in a university hospital during a 5-year period

Medicina

Volumn 47, Issue 7, 2011, Pages 361-367

  Vitkauskiene, Astra ^a   Skrodeniene, Erika ^a   Jomantiene, Daiva ^a   Macas, Andrius ^a   Sakalauskas, Raimundas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Antibiotic resistance; O serogroup; Pseudomonas aeruginosa

Indexed keywords

EID: 84856668878     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina47070051     Document Type: Article

References (24)

1. Di Martino P, Garniere H, Berry H, Bret L. Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patients. Microbes Infect 2002;4:613-20.
2. Matar GM, Chaar MH, Araj GF, Srour Z, Jamaleddine G, Hadi U. Detection of a highly prevalent and potentially virulent strain of Pseudomonas aeruginosa from nosocomial infections in a medical center. BMC Microbiology 2005;5:29.
3. Kareivienė V. Dažniausiu{ogonek} pūlinės infekcijos sukėlėju{ogonek}, nustatytu{ogonek} Kauno miesto gydymo istaigose, atsparumo antibiotikams analizė. (Analysis of most common purulent infection agents resistance to antibiotics aquired at Kaunas health institutions.) [Dissertation]. Kaunas: KMU; 2003.
4. Gailienė G. Pseudomonas aeruginosa atsparumo antibiotikams ir serogrupinės priklausomybės ypatumu{ogonek} sa{ogonek}sajos. (The links of pecularities of Pseudomonas aeruginosa resistance to antibiotics and of its different serogroups.) [Dissertation]. Kaunas: KMU; 2004.
5. Tassios PT, Gennimata V, Maniatis AN, Fock C, Legakis NJ. Emergence of multidrug resistance in uniquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study Group. J Clin Microbiol 1998;36:897-901.
6. Patzer J, Dzierzanowska D. The resistance patterns and serotypes of Pseudomonas aeruginosa strains isolated from chil dren. J Antimicrob Chemother 1991;28:869-75.
7. Alverdy J, Zaborina O, Wu L. The impact of stress and nutrition on bacterial-host interactions at the intestinal epithelial surface. Curr Opin Clin Nutr Metab Care 2005;8:205-9.
8. Zaborina O, Kohler JE, Wang Y, Bethel C, Shevchenko O, Wu L, et al. Identifi cation of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier. Ann Clin Microbiol Antimicrob 2006;5:14.
9. Farmer JJ, Weinstein RA, Zierdt CH, Brokopp CD. Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O:11. J Clin Microbiol 1982;16(2):266-70.
10. Vitkauskienė A. Pathogenicity factors of potential hospitalacquired pneumonia pathogens, Pseudomonas aeruginosa and Klebsiella pneumoniae, and their infl uence on the course of disease. (Potencialiu{ogonek} hospitalinės pneumonijos sukėlėju{ogonek} Pseudomonas aeruginosa ir Klebsiella pneumoniae patogeniškumo veiksniai ir ju{ogonek} itaka ligos eigai.) [Dissertation]. Kaunas: KMU; 2008.
11. Klinikiniu{ogonek} mikrobiologiniu{ogonek} tyrimu{ogonek} metodinės rekomendacijos. Kauno medicinos universitetas Klinikinės mikrobiologijos centras, Lietuvos Respublikos sveikatos apsaugos ministerija, Higienos institutas. Vilnius; 1999.
12. Gaynes R, Edwards JR; National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41: 848-54.
13. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United Stated, 1998 to 2001. Antimicrob Agents Che mother 2003;47(5):1681-8.
14. Leroy O, Giradie P, Yazdanpanah Y, Georges H, Alfandari S, Sanders V, et al. Hospital-acquired pneumonia: microbiological data and potential adequacy of antibiotic regimes. Eur Respir J 2002;20:432-9.
15. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004;125:1791-9.
16. Alonso A, Campanario E, Martinez JL. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 1999;145:2857-62.
17. Hibbertrogers LCF, Heritage J, Gascoynebinzi DM, Hawkey PM, Todd N, Lewis IJ, et al. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother 1995; 36:65-82.
18. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin Infect Dis 2004; 39(1):31-7.
19. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39(6):2206-12.
20. Cryz SJ, Pitt TL, Fürer E, Germanier R. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun 1984;44:508-13.
21. 6. Infect Immun 1994;62:809-17.
22. Goossens H. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibilities between countries and centre types. J Antimicrob Chemother 2000;46(Suppl B):39-52.
23. Savas L, Duran N, Savas N, Ölner Y, Ocak S. The prevalence and resistance patterns of Pseudomonas aeruginosa in Intensive care units in a University hospital. Turk J Med Sci 2005;35:317-22.
24. Leclercq R. Safeguarding future antimicrobial options: strategies to minimize resistance. Clin Microbiol Infect 2001;7: 18-23.